Related references
Note: Only part of the references are listed.Adverse Side Effects Associated with Corticosteroid Therapy: A Study in 39 Patients with Generalized Myasthenia Gravis
Stephen Johnson et al.
MEDICAL SCIENCE MONITOR (2021)
Long-term outcomes and prognostic factors in generalized myasthenia gravis
Yukiko Ozawa et al.
JOURNAL OF NEUROLOGY (2021)
Subgroup stratification and outcome in recently diagnosed generalized myasthenia gravis
Matthias Tomschik et al.
NEUROLOGY (2020)
Predictive score for oral corticosteroid-induced initial worsening of seropositive generalized myasthenia gravis
Tetsuya Kanai et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2019)
Oral corticosteroid dosing regimen and long-term prognosis in generalised myasthenia gravis: a multicentre cross-sectional study in Japan
Tomihiro Imai et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2018)
Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study
James F. Howard et al.
LANCET NEUROLOGY (2017)
EARLY FAST-ACTING TREATMENT STRATEGY AGAINST GENERALIZED MYASTHENIA GRAVIS
Kimiaki Utsugisawa et al.
MUSCLE & NERVE (2017)
Rituximab as treatment for anti-MuSK myasthenia gravis Multicenter blinded prospective review
Michael K. Hehir et al.
NEUROLOGY (2017)
International consensus guidance for management of myasthenia gravis: Executive summary
Donald B. Sanders et al.
NEUROLOGY (2016)
Myasthenia gravis: subgroup classification and therapeutic strategies
Nils Erik Gilhus et al.
LANCET NEUROLOGY (2015)
Complete stable remission and autoantibody specificity in myasthenia gravis
Fulvio Baggi et al.
NEUROLOGY (2013)
Rituximab in refractory and non-refractory myasthenia: A retrospective multicenter study
Nicolas Collongues et al.
MUSCLE & NERVE (2012)
THE MG-QOL15 JAPANESE VERSION: VALIDATION AND ASSOCIATIONS WITH CLINICAL FACTORS
Masayuki Masuda et al.
MUSCLE & NERVE (2012)
Early Aggressive Treatment Strategy against Myasthenia Gravis
Yuriko Nagane et al.
EUROPEAN NEUROLOGY (2011)
Factors associated with depressive state in patients with myasthenia gravis: a multicentre cross-sectional study
Yasushi Suzuki et al.
BMJ OPEN (2011)
Immunosuppressive therapies in myasthenia gravis
Donald B. Sanders et al.
AUTOIMMUNITY (2010)
Autoimmune myasthenia gravis: emerging clinical and biological heterogeneity
Matthew N. Meriggioli et al.
LANCET NEUROLOGY (2009)
Lifetime course of myasthenia gravis
David Grob et al.
MUSCLE & NERVE (2008)
Myasthenia gravis - Recommendations for clinical research standards
A Jaretzki et al.
NEUROLOGY (2000)
Share Paper
